MX9206611A - Acilamidas y ureas del acido quinolilmetoxifenilacetico, procedimiento para su fabricacion y medicamento que las contiene - Google Patents

Acilamidas y ureas del acido quinolilmetoxifenilacetico, procedimiento para su fabricacion y medicamento que las contiene

Info

Publication number
MX9206611A
MX9206611A MX9206611A MX9206611A MX9206611A MX 9206611 A MX9206611 A MX 9206611A MX 9206611 A MX9206611 A MX 9206611A MX 9206611 A MX9206611 A MX 9206611A MX 9206611 A MX9206611 A MX 9206611A
Authority
MX
Mexico
Prior art keywords
quinolylmetoxyphenylacetic
acilamides
ureas
procedure
manufacture
Prior art date
Application number
MX9206611A
Other languages
English (en)
Spanish (es)
Inventor
Siegfried Raddatz
Klauz-Helmut Mohrs
Michael Matzke
Romanis Fruchtmann
Armin Hatzelmann
Reiner Muller Peddinghaus
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of MX9206611A publication Critical patent/MX9206611A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
MX9206611A 1991-12-03 1992-11-17 Acilamidas y ureas del acido quinolilmetoxifenilacetico, procedimiento para su fabricacion y medicamento que las contiene MX9206611A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4139750A DE4139750A1 (de) 1991-12-03 1991-12-03 Chinolylmethoxyphenylessigsaeure-acylamide und -harnstoffe

Publications (1)

Publication Number Publication Date
MX9206611A true MX9206611A (es) 1993-06-01

Family

ID=6446115

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9206611A MX9206611A (es) 1991-12-03 1992-11-17 Acilamidas y ureas del acido quinolilmetoxifenilacetico, procedimiento para su fabricacion y medicamento que las contiene

Country Status (15)

Country Link
US (1) US5288733A (en:Method)
EP (1) EP0545171A1 (en:Method)
JP (1) JPH05246993A (en:Method)
AU (1) AU654067B2 (en:Method)
CA (1) CA2084161A1 (en:Method)
CZ (1) CZ355992A3 (en:Method)
DE (1) DE4139750A1 (en:Method)
FI (1) FI925468L (en:Method)
HU (2) HU9203813D0 (en:Method)
IL (1) IL103925A0 (en:Method)
MX (1) MX9206611A (en:Method)
NO (1) NO924466L (en:Method)
NZ (1) NZ245326A (en:Method)
TW (1) TW222623B (en:Method)
ZA (1) ZA929332B (en:Method)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4443892A1 (de) * 1994-12-09 1996-06-13 Bayer Ag 4-(Chinolin-2-yl-methoxy)-phenyl-essigsäurederivate
WO2001085706A1 (en) * 2000-05-08 2001-11-15 F. Hoffmann-La Roche Ag Substituted phenylacetamides and their use as glucokinase activators
CA2547518A1 (en) 2003-12-12 2005-06-30 Wyeth Quinolines useful in treating cardiovascular disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3814504A1 (de) * 1988-04-29 1989-11-09 Bayer Ag (alpha)-substituierte 4-(chinolin-2-yl-methoxy)phenylessigsaeuren und -ester, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3900261A1 (de) * 1988-05-31 1989-12-07 Bayer Ag Substituierte 4-(chinolin-2-yl-methoxy) phenyl-essigsaeure-derivate
DE3916663A1 (de) * 1989-05-23 1990-11-29 Bayer Ag Substituierte (chinolin-2-yl-methoxy)phenyl-acyl-sulfonamide und -cyanamide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3927369A1 (de) * 1989-08-19 1991-02-21 Bayer Ag Substituierte n-(chinolin-2-yl-methoxy)benzyl-sulfonyl-harnstoffe
DE3935491A1 (de) * 1989-10-25 1991-05-02 Bayer Ag Substituierte (chinolin-2-yl-methoxy)phenyl-carbonylharnstoffe
DE4139751A1 (de) * 1991-12-03 1993-06-09 Bayer Ag, 5090 Leverkusen, De Thiazolyl substituierte chinolylmethoxyphenylessigsaeurederivate
DE4139749A1 (de) * 1991-12-03 1993-06-09 Bayer Ag, 5090 Leverkusen, De Chinolylmethoxyphenyl-essigsaeureamide

Also Published As

Publication number Publication date
AU654067B2 (en) 1994-10-20
JPH05246993A (ja) 1993-09-24
IL103925A0 (en) 1993-04-04
NO924466L (no) 1993-06-04
FI925468A7 (fi) 1993-06-04
FI925468L (fi) 1993-06-04
NO924466D0 (no) 1992-11-19
CA2084161A1 (en) 1993-06-04
CZ355992A3 (en) 1993-06-16
US5288733A (en) 1994-02-22
FI925468A0 (fi) 1992-12-01
EP0545171A1 (de) 1993-06-09
HU9203813D0 (en) 1993-03-29
DE4139750A1 (de) 1993-06-09
TW222623B (en:Method) 1994-04-21
NZ245326A (en) 1995-07-26
ZA929332B (en) 1993-06-04
AU2980092A (en) 1993-06-10
HUT67015A (en) 1995-01-30

Similar Documents

Publication Publication Date Title
MX174542B (es) Procedimiento para la polimerizacion del acido itaconico
ZA807911B (en) Sulfonyl ureas, process for their manufacture, pharmaceutical formulations on the basis of these compounds, and their use
MX9205208A (es) Compuestos derivados del acido 5-amino-4-hidroxihexanoico, procedimiento para su preparacion y compociciones farmaceuticas que los contienen
IT8948426A0 (it) Derivati di acido 3-indolpiruvico, loro procedimento di produzione ed impiego terapeutico
IT1162279B (it) Procedimento per la produzione di tereftalato di polietilene stabile e prodotto ottenuto
PT83909B (pt) Processo para a preparacao de 5-amino e 5-hidroxi-6,8-difluoroquinolonas e de composicoes farmaceuticas antibacterianas que as contem
MX9205916A (es) Derivados de acido ciclohexanoacetico, proceso para su preparacion y composicion farmaceutica que los comprende
MX9205435A (es) Derivados del acido imidazolil-propenico substituidos y procedimiento para su fabricacion.
MX9202153A (es) Compuesto inhibidores del enzyma carnitina aciltransferasa 1 (cat-1) procedimiento para su obtencion y medicamento que los contiene.
MX9205434A (es) Derivados del acido imidazolil-propenico substituidos ciclicamente y procedimiento para su fabricacion.
MX19242A (es) Derivados del acido 2,2-dimetil-3-(2-monohalogenoetenil)-coclopropano-carboxilico, su procedimiento de preparacion y su aplicacion como medicamento.
MX9205436A (es) Derivados del acido imidazolil-propenico y procedimiento para su fabricacion
NO883465L (no) Fremgangsmaate og mellomprodukter for fremstilling av 1-fenyl-3-(1-piperazinyl)-1h-indazoler, og anvendelse derav som medikamenter.
ES2018667B3 (es) Derivados del acido 4-qionolon-3-carboxilico, procedimiento para su obtencion y preparados farmaceuticos que los contienen.
ES2099331T3 (es) Esteres del acido piridiloxi-acrilico.
PT88335A (pt) Processo para a preparacao de derivados do acido 1,4-dihidro-4-oxo-3-quinolinocarboxilico e de composicoes farmaceuticas que os contem
MX9100258A (es) Derivado del acido ciclopropilacetico y procedimiento para su preparacion
MX9206612A (es) Amidas del acido quinolilmetoxifenilacetico, procedimiento para su fabricacion y medicamento que las contiene
DE59002899D1 (de) Aromatische carbonsaeureamide, ihre herstellung und verwendung fuer heilmittel.
MX9206611A (es) Acilamidas y ureas del acido quinolilmetoxifenilacetico, procedimiento para su fabricacion y medicamento que las contiene
ES537480A0 (es) Procedimiento para la fabricacion de la reductasa del acido 2, 5-diceto-d-gluconico
AR223518A1 (es) Esteres o-pirazolilicos del acido n,n-dimetil-carbamico,procedimiento para su produccion y composiciones plaguicidas que los contienen
AR229036A1 (es) 1-benzoil-3-((2,2-diclorociclopropiloxi)-fenil)-ureas sustituidas,composiciones insecticidas que las contienen y procedimientos para producirlas
IT8022565A0 (it) Procedimento per la produzione di acido cloridico ed amoniaca.
MX9205775A (es) Pirrolidinas substituidas, procedimiento para su fabricacion y medicamento que las contiene